Barbara Klencke - Jun 13, 2023 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Director
Signature
/s/ Barbara Klencke
Stock symbol
TCRX
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 06:13 PM
Previous filing
Apr 10, 2023
Next filing
Jun 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (Right to Buy) Award $0 +36.5K $0.00 36.5K Jun 13, 2023 Voting Common Stock 36.5K $2.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 35,000 shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 13, 2024 and (ii) the next annual meeting of the Issuer's stockholders, with 1,524 shares subject to this option vesting and becoming exercisable in full on June 13, 2023, in each case subject to the Reporting Person's continued service at such time.